title: Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complex.
abstract: Transcutaneous immunization presents a major challenge on account of poor permeability of antigens through the skin barrier. To overcome this limitation, the deformable liposome could be a better method for transcutaneous delivery of these antigens. In this study, hepatitis B surface antigen (HBsAg) plasmid DNA-cationic complex deformable liposome was utilized as a mode for enhanced immunity against the antigen. Deformable liposome was prepared by conventional rotary evaporation method and characterized for various parameters such as vesicles shape and surface morphology, size and size distribution, entrapment efficiency, elasticity and stability. The immune stimulating activity was studied by measuring serum anti-HBsAg titre and cytokines level (interleukin-4 and interferon-gamma) following topical application of liposome in BALB/c mice and results were compared with deformable liposome encapsulated DNA applied topically as well as naked DNA and pure recombinant HBsAg, administered intramuscularly. It was observed that deformable liposome elicited a comparable serum antibody titre and endogenous cytokines levels compared to other vaccinations. The study signifies the potential of deformable liposome as DNA vaccine carriers for effective transcutaneous immunization.
authors: Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai, China.
authors: Jing
authors: J
authors: Wang
authors: Jin-hong
authors: JH
authors: Hu
authors: Feng-qian
authors: FQ
authors: Li
authors: Guan-zhong
authors: GZ
authors: Liu
authors: Quan-gang
authors: QG
authors: Zhu
authors: Ji-yong
authors: JY
authors: Liu
authors: Hong-jun
authors: HJ
authors: Ma
authors: Cheng
authors: C
authors: Peng
authors: Fu-guo
authors: FG
authors: Si
mesh_terms: D000276:Adjuvants, Immunologic; D000279:Administration, Cutaneous; D000287:Administration, Topical; D000818:Animals; D000906:Antibodies / Q000378:metabolism*; D002463:Cell Membrane Permeability / Q000502:physiology; D004247:DNA / Q000008:administration & dosage* / Q000276:immunology; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000235:genetics* / Q000276:immunology; D007114:Immunization / Q000379:methods*; D007273:Injections, Intramuscular; D007371:Interferon-gamma / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D008081:Liposomes; D051379:Mice; D008807:Mice, Inbred BALB C; D012867:Skin / Q000166:cytology
chemical_list: D000276:Adjuvants, Immunologic; D000906:Antibodies; D006514:Hepatitis B Surface Antigens; D008081:Liposomes; D015847:Interleukin-4; D007371:Interferon-gamma; D004247:DNA